VeriSIM Life (VeriSIM), which provides an artificial intelligence (AI) solution to assess risk in pharmaceutical research and development, recently announced that it has entered into a partnership agreement with Total Brain, an applied, integrative neuroscience company. The strategic collaboration will focus on creating insights for the development of novel drugs to treat a wide range of neurological disorders including Alzheimer’s disease, Parkinson’s disease, schizophrenia, anorexia nervosa, depression, anxiety, and bipolar disorder among others.

The partnership will pioneer the integration of Total Brain’s proprietary mental health and brain performance database with VeriSIM Life’s BIOiSIM™ AI-enabled drug . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Market Watch

A snapshot of what’s happening across the industry—a one-stop source for key developments across policy and regulatory changes, service and treatment innovations, technological advancements, industry recognition and accreditation, mergers and acquisitions, leadership shifts, and more.

Filter Options

  • By Categories
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters

  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.